Skip to main content
Intended for healthcare professionals
Restricted access
Case report
First published online August 4, 2014

Successful Oral Ciprofloxacin Therapy of Neisseria elongata Endocarditis

Abstract

Objective: To report successful oral ciprofloxacin therapy for Neisseria elongata endocarditis. Case Summary: A patient with N elongata endocarditis refused parenteral therapy, but his infection completely resolved with 7 weeks of oral ciprofloxacin. Discussion: This patient’s refusal of parenteral therapy prompted the use of oral ciprofloxacin because it is well absorbed and was expected to be very active against his organism. His infection resolved and did not relapse. Although successful oral therapy has been reported for endocarditis caused by Staphylococcus aureus, primarily in injection drug users, completely oral therapy for other organisms has not been previously described. Conclusions: When parenteral therapy is not possible, oral administration of highly active, well-absorbed antibiotics may be effective for selected cases of endocarditis caused by susceptible organisms.

Get full access to this article

View all access and purchase options for this article.

References

1. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318-1330.
2. Demonchy E, Dellamonica P, Roger PM, et al. audit of antibiotic therapy used in 66 cases of endocarditis. Med Mal Infect. 2011;41:602-607.
3. Heldman AW, Hartert TV, Ray SC, et al. Oral antibiotic therapy of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med. 1996;10:68-76.
4. Lode H, Hoffken G, Boeckk M, Deppermann N, Borner K, Koeppe P. Quinolone pharmacokinetics and metabolism. J Antimicrob Chemother. 1990;(suppl B):41-49.
5. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638.
6. Dominguez EA, Smith TL. Endocarditis due to Neisseria elongata subspecies nitroreducens: case report and review. Clin Infect Dis. 1998;26:1471-1473.
7. Haddow LJ, Mulgrew C, Snsari A, et al. Neisseria elongata endocarditis: case report and literature review. Clin Microbiol Infect. 2003;9:426-430.
8. Fuller RE, Hayward SL. Oral antibiotic therapy in infective endocarditis. Ann Pharmacother. 1996;30:676-678.
9. Tascini C, Bongiorni MG, Doria R, et al. Linezolid for endocarditis: a case series of 14 patients. J Antimicrob Chemother. 2011;66:679-682.
10. Ravindran V, John J, Kaye G, et al. Successful use of linezolid as a single active agent in endocarditis unresponsive to conventional antibiotic therapy. J Infect. 2003;47:164-166.
11. Lawlor M, Sullivan M, Levitz R, et al. Treatment of prosthetic valve endocarditis due to methicillin-resistant Staphylococcus aureus with minocycline. J Infect Dis. 1990;161:812-814.
12. Naba MR, Araj GF, Kanafani ZA, et al. First case of Pasteurella multocida endocarditis of the tricuspid valve: a favorable outcome following medical treatment. Int J Infect Dis. 2009;5:2267-2269.
13. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA. 1995;274:1706-1713.
14. Davis R, Markham A, Balfour J. Ciprofloxacin an updated review of its pharmacology, therapeutic efficacy, and tolerability. Drugs. 1996;51:1019-1074.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
EMAIL ARTICLE LINK
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published online: August 4, 2014
Issue published: November 2014

Keywords

  1. Neisseria elongata
  2. endocarditis
  3. oral
  4. ciprofloxacin
  5. treatment

Rights and permissions

© The Author(s) 2014.
Request permissions for this article.
PubMed: 25092687

Authors

Affiliations

David A. Herbert, MD
Kaiser Permanente Medical Center and University of California at Davis, Sacramento, CA, USA

Notes

David A. Herbert, Kaiser Permanente Medical Center, 2025 Morse Avenue, Sacramento, CA 95825, USA. Email: [email protected]

Metrics and citations

Metrics

Journals metrics

This article was published in Annals of Pharmacotherapy.

VIEW ALL JOURNAL METRICS

Article usage*

Total views and downloads: 176

*Article usage tracking started in December 2016


Altmetric

See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores



Articles citing this one

Receive email alerts when this article is cited

Web of Science: 6 view articles Opens in new tab

Crossref: 3

  1. The resistance mechanisms of bacteria against ciprofloxacin and new ap...
    Go to citation Crossref Google Scholar
  2. An Unusual cause of Endocarditis
    Go to citation Crossref Google Scholar
  3. Genomic analysis of Neisseria elongata iso...
    Go to citation Crossref Google Scholar

Figures and tables

Figures & Media

Tables

View Options

Get access

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text